tradingkey.logo
tradingkey.logo
Search

Faeth Therapeutics Ord Shs

FTH
Add to Watchlist
27.250USD
+0.010+0.04%
Close 07-31 16:00ETQuotes delayed by 15 min
36.52MMarket Cap
--P/E TTM

Faeth Therapeutics Ord Shs

27.250
+0.010+0.04%

More Details of Company

Faeth Therapeutics Ord Shs Info

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of Faeth Therapeutics Ord Shs

Name
Name/Position
Position
Shareholding
Change
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Josiah Craver
Mr. Josiah Craver
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
--
--
Mr. Christopher W. Gerry
Mr. Christopher W. Gerry
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Phillip B. Donenberg
Mr. Phillip B. Donenberg
Independent Director
Independent Director
--
--
Mr. Anand K. Parikh, J.D.
Mr. Anand K. Parikh, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
--
--
Ms. Saira Ramasastry
Ms. Saira Ramasastry
Director
Director
--
--
Ms. Karen Vousden
Ms. Karen Vousden
Director
Director
--
--
Mr. Brian Stephenson, Ph.D.
Mr. Brian Stephenson, Ph.D.
Chief Financial Officer and Principal Financial Officer
Chief Financial Officer and Principal Financial Officer
--
--
Mr. Oliver Maddocks, Ph.D.
Mr. Oliver Maddocks, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Josiah Craver
Mr. Josiah Craver
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
--
--
Mr. Christopher W. Gerry
Mr. Christopher W. Gerry
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Phillip B. Donenberg
Mr. Phillip B. Donenberg
Independent Director
Independent Director
--
--
Mr. Anand K. Parikh, J.D.
Mr. Anand K. Parikh, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
--
--

FAQs

Who are the top five shareholders of Faeth Therapeutics Ord Shs?

The top five shareholders of Faeth Therapeutics Ord Shs are: Mr. Bob Holmen
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.